An innovative advance for the service to the patient
NAVELBINE® Oral = NAVELBINE® I.V.
Similar efficacy (1)
- Response rate
- Progression-free survival
- Overall survival
Qualitatively comparable tolerance profile
Improved patient management
Patient comfort
|
Patient safety
|
Cost savings
|
Correspondence of doses
NAVELBINE® Oral |
NAVELBINE® I.V. |
| 80 mg/m² | 30mg/m² |
| 60 mg/m² | 25mg/m² |
Administration
Once a week in a single administration
60 mg/m²/week for the first 3 administrations followed by 80 mg/m²/week depending on the blood count.
(1) Jassem J. et al : A multicenter randomized phase II study of oral vs.intravenous vinorelbine in advanced non-small-cell lung cancer patients. Ann. Oncology 2001; 12: 1375-1381